Ajax-Loading

Takeda Pharmaceutical Co. Ltd. - Receivables Turnover

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March.

The item "Receivables-Turnover" stands at 6.22 as of 09/30/2025.

As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Receivables Turnover" stands at 6.22. This represents a decrease of -0.76 percent compared to it's value at the end of it's first quarter .


Regarding the One-Year-Change of the series, the current value constitutes an increase of 0.3067 percent compared to the value the year prior.
The 1 year change in percent is 0.3067.
The 3 year change in percent is 27.47.

The Serie's long term average value is 5.54. It's latest available value, on 09/30/2025, is 12.30 percent higher, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 03/31/2022, to it's latest available value, on 09/30/2025, is +40.51%.
The Serie's change in percent from it's maximum value, on 06/30/2025, to it's latest available value, on 09/30/2025, is -0.759%.

Receivables Turnover for Related Companies:

LogoNameMarket Cap (USD)
LogoEli Lilly and Company - Receivables Turnover905,699,262,464.00
LogoJohnson & Johnson - Receivables Turnover486,508,953,600.00
LogoAbbVie Inc - Receivables Turnover399,570,305,024.00
LogoRoche Holding AG - Receivables Turnover317,433,206,677.55
LogoAstraZeneca PLC - Receivables Turnover280,205,508,085.11